Artiva Biotherapeutics, Inc. (ARTV) › Cash & EquivalentsArtiva Biotherapeutics, Inc. (ARTV) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2023-12-31: $53.50M2024-12-31: $40.23M2025-12-31: $26.70M$26.70M2023-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$26.70M-33.6%2026-03-10Balance as of period end2024-12-31$40.23M-24.8%2026-03-10Balance as of period end2023-12-31$53.50M—2025-03-24Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)